Prestige Consumer Healthcare (PBH) Change in Account Payables (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Change in Account Payables of -$4.1 million for Q4 2025, up 63.68% year-over-year from -$2.5 million in Q4 2024, and down 120.66% quarter-over-quarter from $19.8 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Change in Account Payables (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Change in Account Payables history runs 16 years deep, the most recent figure standing at -$4.1 million for Q4 2025.
- In Q4 2025, Change in Account Payables rose 63.68% year-over-year to -$4.1 million; the TTM figure through Dec 2025 stood at $17.9 million (up 190.12% YoY), while the FY2025 annual figure was -$19.4 million, up 22.27% from the prior year.
- Change in Account Payables for Q4 2025 stood at -$4.1 million, down from $19.8 million in the prior quarter.
- The five-year high for Change in Account Payables was $19.8 million in Q3 2025, with the low at -$15.6 million in Q2 2021.
- The 5-year median for Change in Account Payables is -$783500.0 (2024), against an average of $446700.0.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables slumped 766.38% in 2023, then surged 366.33% in 2025.
- Prestige Consumer Healthcare's Change in Account Payables stood at $2.2 million in 2021, then surged by 258.65% to $7.9 million in 2022, then plunged by 165.31% to -$5.1 million in 2023, then slumped by 118.8% to -$11.3 million in 2024, then jumped by 63.68% to -$4.1 million in 2025.
- Business Quant data shows PBH's Change in Account Payables at -$4.1 million in Q4 2025, $19.8 million in Q3 2025, and $2.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.09 Mn |
| Dec 31, 2025 | -4.09 Mn |
| Sep 30, 2025 | 19.79 Mn |
| Sep 30, 2025 | 19.79 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Mar 31, 2025 | -560,000.00 |
| Mar 31, 2025 | -560,000.00 |
| Dec 31, 2024 | -11.26 Mn |
| Dec 31, 2024 | -11.26 Mn |
| Sep 30, 2024 | -8.19 Mn |
| Sep 30, 2024 | -8.19 Mn |
| Jun 30, 2024 | 591,000.00 |
| Jun 30, 2024 | 591,000.00 |
| Mar 31, 2024 | -1.01 Mn |
| Mar 31, 2024 | -1.01 Mn |
| Dec 31, 2023 | -5.14 Mn |
| Dec 31, 2023 | -5.14 Mn |
| Sep 30, 2023 | -13.22 Mn |
| Sep 30, 2023 | -13.22 Mn |